June 1, 2026 — This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) is advancing the commercial evaluation of its Lawson natural hydrogen discovery in Saskatchewan as growing artificial intelligence infrastructure drives unprecedented demand for electricity and clean baseload energy.
June 1, 2026 — This article has been disseminated on behalf of Helus Pharma and may include paid advertising. Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP), a clinical-stage pharmaceutical company developing novel serotonergic agonists, announced that Interim Chief Executive Officer Eric So will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York.
June 1, 2026 — Oncotelic Therapeutics maintained the fair value of its 45% GMP Biotechnology JV stake at approximately $388 million in Q1 2026 despite broader biotech market volatility The valuation was supported by an independent ASC 820 Level 3 assessment using discounted cash flow analysis and market comparables These developments reinforce Oncotelic’s partnership-driven model, designed to advance a multi-billion-dollar oncology pipeline while limiting traditional biotech cash burn pressures Oncotelic Therapeutics (OTCQB: OTLC) continues to distinguish itself within a biotechnology sector often characterized by aggressive capital raises and persistent cash burn. In its recently filed first-quarter 2026 financial results, the company maintained the fair value of its 45% ownership stake in GMP Biotechnology Limited at approximately $388 million, signaling relative stability during a period in which many emerging biotech valuations have faced significant downward pressure (ibn.
June 1, 2026 — Oncotelic Therapeutics maintained the fair value of its 45% GMP Biotechnology JV stake at approximately $388 million in Q1 2026 despite broader biotech market volatility The valuation was supported by an independent ASC 820 Level 3 assessment using discounted cash flow analysis and market comparables These developments reinforce Oncotelic’s partnership-driven model, designed to advance a multi-billion-dollar oncology pipeline while limiting traditional biotech cash burn pressures Oncotelic Therapeutics (OTCQB: OTLC) continues to distinguish itself within a biotechnology sector often characterized by aggressive capital raises and persistent cash burn. In its recently filed first-quarter 2026 financial results, the company maintained the fair value of its 45% ownership stake in GMP Biotechnology Limited at approximately $388 million, signaling relative stability during a period in which many emerging biotech valuations have faced significant downward pressure (https://nnw.
June 1, 2026 — Nightfood Holdings (OTCQB: NGTF) announced that its subsidiary, TechForce Robotics, has successfully completed Phase 1 objectives under its joint development agreement with Oncotelic Therapeutics (OTCQB: OTLC), highlighted by the initial deployment of LIM-E, an autonomous laboratory support robot. The deployment marks TechForce’s first expansion into pharmaceutical and laboratory automation and validates the adaptability of its AI-enhanced robotics platform beyond hospitality and service-industry applications into life sciences and pharmaceutical environments.
June 1, 2026 — Nightfood Holdings (OTCQB: NGTF) announced that its subsidiary, TechForce Robotics, has successfully completed Phase 1 objectives under its joint development agreement with Oncotelic Therapeutics (OTCQB: OTLC), highlighted by the initial deployment of LIM-E, an autonomous laboratory support robot. The deployment marks TechForce’s first expansion into pharmaceutical and laboratory automation and validates the adaptability of its AI-enhanced robotics platform beyond hospitality and service-industry applications into life sciences and pharmaceutical environments.
June 1, 2026 — This article has been disseminated on behalf of Trilogy Metals Inc. and may include paid advertising.
June 1, 2026 — This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) announced a memorandum of understanding with TerraVolt Energy, EcoTech Building Solutions and Carbon Neutral Growth Fund to evaluate integrating Natural Hydrogen production, modular power systems, sustainable building infrastructure and associated brine waters from the Lawson Complex into next-generation artificial intelligence and high-performance computing infrastructure.
June 1, 2026 — Strawberry Fields REIT (NYSE AMERICAN: STRW) announced that Chairman and CEO Moishe Gubin will present at Planet MicroCap Las Vegas 2026 Powered by MicroCapClub on June 17, 2026, at the Bellagio Resort & Hotel in Las Vegas. Gubin is scheduled to deliver the company presentation and participate in a question-and-answer session, while management will also be available for one-on-one investor meetings during the conference.
June 1, 2026 — This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.
June 1, 2026 — This article has been disseminated on behalf of McEwen Inc. and may include paid advertising.
June 1, 2026 — FingerMotion (NASDAQ: FNGR) reported financial results for the fiscal year ended Feb. 28, 2026, with revenue of $24.
June 1, 2026 — Datavault AI (NASDAQ: DVLT) a provider of data monetization, credentialing, digital engagement and real-world asset (“RWA”) tokenization technologies, announced the execution of a non-binding term sheet for a potential $2 billion dilutive structured financing transaction intended to support its digital asset exchanges and RWA tokenization strategies. The proposed transaction is expected to be structured across four successive tranches of up to $500 million each, with the initial tranche targeting completion by the third quarter of 2026, and includes strategic exclusivity for the counterparty digital asset tokenization projects through Datavault AI patented platform unless otherwise agreed.
June 1, 2026 — MindWave Innovations is building institutional-grade digital asset treasury infrastructure designed to help corporations manage Bitcoin holdings through custody, reporting, and yield-generation capabilities The company’s broader ecosystem spans AdTech, InsurTech and ClimateTech, creating a multi-vertical blockchain-enabled platform Following its reverse merger with Apimeds Pharmaceuticals US, MindWave is now positioned as a publicly traded digital asset infrastructure company on the NYSE American In corporate finance, treasury management has traditionally centered on capital preservation, liquidity, internal controls, and predictable yield. That framework is being tested as a growing number of companies leaning into Bitcoin not as a speculative trade, but as a strategic treasury asset.
May 29, 2026 — Missouri cannabis regulators are preparing for a statewide outreach effort ahead of the final lottery that will distribute 77 microbusiness marijuana permits, with officials hoping recent policy changes will strengthen oversight and reduce problems that have troubled earlier rounds. As these microbusiness licenses are issued and the recipients launch their operations, other opportunities could be created within the marijuana industry ecosystem for services similar to what firms like Innovative Industrial Properties Inc.
May 29, 2026 — Disseminated on behalf of Lahontan Gold Corp. (TSX.
May 29, 2026 — Disseminated on behalf of CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) and may include paid advertising.
May 29, 2026 — Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) (FSE: P6U) and may include paid advertising.
May 29, 2026 — Aegis Capital announced its involvement in the secondary sale of an approximately $15 million stake in Perplexity. The firm also recognized the contributions of Devin A.
May 29, 2026 — Regentis Biomaterials Ltd. (NYSE American: RGNT) is advancing GelrinC®, a cell-free hydrogel implant designed to simplify knee cartilage repair through a single-step, approximately 10-minute procedure that may offer an alternative to traditional microfracture and complex cell-based therapies.
